Last modified on Tue 4 May 2021 12.32 EDT
When Minna Heeraman’s friends knew that she was dying, they made a video for her to watch from the hospital bed she had set up in her living room. It was a goodbye video. One after another, her friends spoke to the camera with tears in their eyes. They shared their memories of times spent together. Wine in the garden on sunny afternoons. Hen dos. Weddings. Christmas meet-ups. “I don’t know what more to say, Minna,” says one friend, choking back sobs. “I love you so much. And you’ll always be with us.”
Government injects £37m into genomics and data-driven initiatives
30th April 2021
Health and Social Care Secretary Matt Hancock has announced new funding for genomics projects and data-driven initiatives as part of plans to ‘transform’ the UK life sciences industry.
Hancock revealed the government’s plans for the UK life sciences sector during the Association of the British Pharmaceutical Industry’s (ABPI) Annual Conference yesterday.
The plans set out the government’s aims to ‘harness the momentum’ created during the COVID-19 response, to transform the UK life sciences sector into a ‘superpower’.
This includes £37m worth of new investments for genomics projects and data-driven initiatives.
29 April 2021
£37 million for genomics projects and for data-driven initiatives delivered through the Genome UK Implementation Plan and the UK Functional Genomics Initiative
Pledge to make the UK a global leader in manufacturing, especially for medicines, to grow UK-based business and encourage investment
Patients are set to benefit from better research, treatment, care and improved clinical decision-making, as the Secretary of State for Health and Social Care Matt Hancock set out his plans for the future of the UK life sciences sector at the Association of the British Pharmaceutical Industry (
ABPI) annual conferencee today.
The life sciences sector made significant leaps in response to the COVID pandemic, from finding innovative treatments for the virus including dexamethasone and launching the first Antivirals Taskforce, to rolling out one of the most successful vaccination programmes in the world. To harness this momentum and ensure the sector’s growth beyond the pandemic
Magnesium Sulfate Market Segment Analysis – By Applications
Fertilizers held the largest share in the magnesium sulfate market in 2020 and are projected to grow at a CAGR of 4.9% during the forecast period 2021-2026. Inorganic crop production, fertilizers composed of synthetic or non-synthetic materials containing synthetic magnesium sulfate can be used as a plant or soil modifications. Magnesium sulfate fertilizer is designed for fast correction or prevention of magnesium deficiencies in all types of crop and soil conditions. The fertilizer is best used before or during planting to avoid magnesium shortages, but it can also be used during the growing season to fix growth problems. Rapid development of magnesium sulfate in fertilizers will in turn propel the market growth over the forecast period.
Matt Hancock today warned the rise of deadly superbugs poses a bigger threat than Covid and should be taken as seriously as global warming.
The Health Secretary said modern medicine may cease to exist unless the silent pandemic of antimicrobial resistance is urgently tackled.
Drug-resistant diseases such as MRSA already kill 700,000 people around the world each year – including 5,000 in Britain.
But experts fear the annual fatality toll could reach 10million by 2050, with common infections such as gonorrhoea and E. coli learning to evade antibiotics.
Matt Hancock called for countries to fight the emergence of MRSA. He is pictured today receiving the AstraZeneca Covid jab at the Science Museum, London